Task: Answer the multiple-choice question.
Query: Which drug exhibits a -8.995\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCOC(=O)CSc1nc2cc(S(=O)(=O)N3CCOCC3)ccc2n1CC
b) NC(=O)c1ccc[n+](CC(=O)Nc2ccccc2C(=O)O)c1.[Cl-]
c) O=C(c1ccccc1)C1CCCN(Cc2nc(-c3cnccn3)no2)C1
Answer: a. CCOC(=O)CSc1nc2cc(S(=O)(=O)N3CCOCC3)ccc2n1CC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)CSc1nc2cc(S(=O)(=O)N3CCOCC3)ccc2n1CC
CCOC(=O)CSc1nc2cc(S(=O)(=O)N3CCOCC3)ccc2n1CC
ethyl2-(1-ethyl-5-morpholin-4-ylsulfonylbenzimidazol-2-yl)sulfanylacetate